[3P] 69 Alzheimer's Disease and Dementia

[3P-310] Developing Therapeutics for Tauopathies via Antisense Modulation of Tau Isoforms

*Shinsuke Ishigaki¹, Kuniyuki Endo², Kentaro Sahashi², Kaori Kawai², Yusuke Fujioka¹, Masahisa Katsuno², Gen Sobue³ (1. Mol Neurosci Res Ctr, Shiga Univ of Med Sci, Otsu, Japan, 2. Grad Sch Med, Nagoya Univ, Nagoya, Japan, 3. Aichi Med Univ, Aichi Med Univ, Nagakute, Japan)

Keywords:tau, antisense oligonucleotide, therapeutics, tauopathy